27951480|t|Development of the four-item Letter and Shape Drawing test (LSD-4): A brief bedside test of visuospatial function
27951480|a|Conventional bedside tests of visuospatial function such as the Clock Drawing (CDT) and Intersecting Pentagons (IPT) lack consistency in delivery and interpretation. We compared performance on a novel test of visuospatial ability - the LSD - with the IPT, CDT and MMSE in 180 acute elderly medical inpatients [mean age 79.7±7.1 (range 62-96); 91 females (50.6%)]. 124 (69%) scored ≤23 on the MMSE; 60 with mild (score 18-23) and 64 with severe (score ≤17) impairment. 78 (43%) scored ≥6 on the CDT, while for the IPT, 87 (47%) scored ≥4. The CDT and IPT agreed on the classification of 138 patients (77%) with modest- strong agreement with the MMSE categories. Correlation between the LSD and visuospatial tests was high. A four-item version of the LSD incorporating items 1,10,12,15 had high correlation with the LSD-15 and strong association with MMSE categories. The LSD-4 provides a brief and easily interpreted bedside test of visuospatial function that has high coverage of elderly patients with neurocognitive impairment, good agreement with conventional tests of visuospatial ability and favourable ability to identify significant cognitive impairment. [181 words].
27951480	0	11	Development	T169	C1527148
27951480	19	58	four-item Letter and Shape Drawing test	UnknownType	C0260168
27951480	60	65	LSD-4	UnknownType	C0260168
27951480	76	88	bedside test	T060	C0282662
27951480	92	113	visuospatial function	T041	C2370887
27951480	114	126	Conventional	T080	C0439858
27951480	127	140	bedside tests	T060	C0282662
27951480	144	165	visuospatial function	T041	C2370887
27951480	178	191	Clock Drawing	UnknownType	C0260168
27951480	193	196	CDT	UnknownType	C0260168
27951480	202	224	Intersecting Pentagons	UnknownType	C0260168
27951480	226	229	IPT	UnknownType	C0260168
27951480	231	235	lack	T080	C0332268
27951480	236	247	consistency	T080	C0332529
27951480	264	278	interpretation	T033	C0456377
27951480	283	291	compared	T052	C1707455
27951480	292	303	performance	T052	C1882330
27951480	323	343	visuospatial ability	T041	C0814069
27951480	350	353	LSD	UnknownType	C0260168
27951480	365	368	IPT	UnknownType	C0260168
27951480	370	373	CDT	UnknownType	C0260168
27951480	378	382	MMSE	T060	C0451306
27951480	390	395	acute	T079	C0205178
27951480	396	403	elderly	T098	C0001792
27951480	404	411	medical	T169	C0205476
27951480	412	422	inpatients	T101	C0021562
27951480	424	428	mean	T081	C0444504
27951480	429	432	age	T032	C0001779
27951480	443	448	range	T081	C1514721
27951480	460	467	females	T032	C0086287
27951480	488	494	scored	T081	C0449820
27951480	506	510	MMSE	T060	C0451306
27951480	520	524	mild	T080	C2945599
27951480	526	531	score	T081	C0449820
27951480	551	557	severe	T080	C0205082
27951480	559	564	score	T081	C0449820
27951480	570	580	impairment	T169	C0221099
27951480	591	597	scored	T081	C0449820
27951480	608	611	CDT	UnknownType	C0260168
27951480	627	630	IPT	UnknownType	C0260168
27951480	641	647	scored	T081	C0449820
27951480	656	659	CDT	UnknownType	C0260168
27951480	664	667	IPT	UnknownType	C0260168
27951480	668	674	agreed	T033	C3641827
27951480	682	696	classification	T185	C0008902
27951480	704	712	patients	T101	C0030705
27951480	732	738	strong	T080	C0442821
27951480	758	762	MMSE	T060	C0451306
27951480	763	773	categories	T170	C0683312
27951480	775	786	Correlation	T080	C1707520
27951480	799	802	LSD	UnknownType	C0260168
27951480	807	825	visuospatial tests	UnknownType	C0260168
27951480	830	834	high	T080	C0205250
27951480	838	855	four-item version	T170	C0333052
27951480	863	866	LSD	UnknownType	C0260168
27951480	881	886	items	T071	C1551338
27951480	902	906	high	T080	C0205250
27951480	907	918	correlation	T080	C1707520
27951480	928	934	LSD-15	UnknownType	C0260168
27951480	939	945	strong	T080	C0442821
27951480	946	962	association with	T080	C0332281
27951480	963	967	MMSE	T060	C0451306
27951480	968	978	categories	T170	C0683312
27951480	984	989	LSD-4	UnknownType	C0260168
27951480	1011	1017	easily	T033	C0332219
27951480	1018	1029	interpreted	T169	C1285553
27951480	1030	1042	bedside test	T060	C0282662
27951480	1046	1067	visuospatial function	T041	C2370887
27951480	1077	1081	high	T080	C0205250
27951480	1082	1090	coverage	T169	C1999244
27951480	1094	1101	elderly	T098	C0001792
27951480	1102	1110	patients	T101	C0030705
27951480	1116	1141	neurocognitive impairment	T048	C0338656
27951480	1163	1175	conventional	T080	C0439858
27951480	1185	1205	visuospatial ability	T041	C0814069
27951480	1232	1240	identify	T080	C0205396
27951480	1241	1252	significant	T078	C0750502
27951480	1253	1273	cognitive impairment	T048	C0338656